For the Biome, the revolutionary new wellness company launched by Paul Schulick, founder of the iconic nutritional supplement company New Chapter, has announced a partnership with microalgae innovator Algatech on topical applications. Based in Israel’s Arava desert, Algatech is known for developing cutting-edge products including AstaPure®Astaxanthin, a premium natural astaxanthin – one of the world’s most powerful antioxidants sourced from the microalga Haematococcus pluvialis.
The announcement comes days after Schulick was presented the highest professional honor as an inductee into the Hall of Legends at Natural Products Expo West in Anaheim, CA on March 7. The previous morning, he was invited as a keynote speaker to reflect on his decades at the creative helm of New Chapter, which was so successful that the company was targeted and then acquired by Procter and Gamble in 2012. After the acquisition, Schulick and his co-founder wife Barbi, remained with the company for six more years. They disclosed their departure from P&G in The Wall Street Journal last summer.
“Our next venture with Algatech will bring unimagined innovations to the field of beauty and natural skincare,” said Schulick, author of three groundbreaking books on herbs and wellness. “The skin is the body’s largest organ and functions as its ‘third brain’ as an extension of the human microbiome. Beauty is truly an expression of deep cellular health, as well as harmony with the expansive hologenome, whose ebb and flow nourishes us all.”
For over 35 years, Schulick led innovation and formulation of the 60+ products in the New Chapter formulary, staying firm to his codified principles that respect nature’s wisdom and herbal synergy. A pioneer in whole food fermentation and supercritical extraction, Schulick’s innovations instigated a trend that has transformed the nutritional supplement industry worldwide. At Expo West, he met with top influencers in fermentation, mushroom science and supercritical extraction to explore future collaborations for topical and ingestible beauty products.
“Our commitment to purity and healing is as strong as it was thirty-five years ago—maybe even stronger, with the benefit of experience,” said Schulick. “For the Biome in partnership with Algatech will introduce exciting new ways to harvest nature’s wisdom.”
“Algatech is proud to collaborate with Paul Schulik and For the Biome on topical applications in order to bring the benefits of microalgae to the world. This partnership will provide new and innovative solutions for the skin, starting with AstaPure®Astaxanthin, a premium natural astaxanthin,” says Hagai Stadler, CEO of Algatech. “In tune with the wisdom and beauty of nature, Algatech develops innovative algae-derived ingredients that support health. The same protective factors that let microalgae develop and remain shielded from exogenous damage for billions of years will also be employed to support the integrity and beauty of the skin in this new partnership”.
Founded in 1998, Algatech is a rapidly growing biotechnology company, specializing in the commercial cultivation of microalgae. The company is a leading astaxanthin manufacturer and produces astaxanthin in an innovative and proprietary process, and markets its AstaPure® brand to the nutrition, food & beverages, and cosmetics industries worldwide. The company has recently launched Fucovital™, Fucoxanthin complex extracted from the microalga Phaeodactylum and AstaPure® Arava whole-algae clean label complex from the microalga Haematococcus Pluvialis.
Foundational Supplement Program with Whole Food AstaPure® Arava - David Foreman, The Herbal Pharmacist, explains why AstaPure Arava fit like a custom-made suit for a sound foundational supplement program
In nature, and so too at Algatech, everything started with microalgae, aquatic single-celled plants. over a billion years of evolution, microalgae survived to become one of nature's most fascinating wonders, and a great source for valuable ingredients
FucoVital shown to be more effective than Silymarin in preventing harmful fat accumulation in liver cells